Filter my results
Search
Displaying 1 - 4 of 4
World Health Organization Guidelines (Option A, B, and B+) for Antiretroviral Drugs to Treat Pregnant Women and Prevent HIV Infection in Infants
By: Sierra Hope Jones, Alexis Darby
| Published: Mar 01, 2021
To address the international Human Immunodeficiency Virus epidemic, the World Health Organization, or WHO, developed three drug treatment regimens…
HIV-positive personsHIV infectionsHIV-positive youthHIV-positive womenHIV-positive children
World Health Organization Guidelines (Option A, B, and B+) for Antiretroviral Drugs to Treat Pregnant Women and Prevent HIV Infection in Infants
By: Sierra Hope Jones, Alexis Darby
| Published: Mar 01, 2021
To address the international Human Immunodeficiency Virus epidemic, the World Health Organization, or WHO, developed three drug treatment regimens…
HIV-positive personsHIV infectionsHIV-positive youthHIV-positive womenHIV-positive children
“The Construction of Lay Expertise: AIDS Activism and the Forging of Credibility in the Reform of Clinical Trials” (1995), by Steven Epstein
By: Jarrett L. Joubert
| Published: Jun 24, 2024
On 1 October 1995, Steven Epstein published “The Construction of Lay Expertise: AIDS Activism and the Forging of Credibility in the Reform of…
HIV SeropositivityAcquired Immunodeficiency SyndromePneumocystis cariniiPneumocystis InfectionsHIV
Zidovudine or Azidothymidine (AZT)
By: Chase V. Florez
| Published: Jun 30, 2020
In 1964, Jerome Horwitz synthesized the drug zidovudine, commonly abbreviated ZDV, otherwise known as azidothymidine, or AZT, at Wayne State…
AZT (Drug)AzidothymidineHIV-positive menHIV-positive childrenHIV-positive women